Self-Amplifying RNA in Vaccines and Beyond

The remarkable success of SARS-CoV2 vaccines has brought to light the incredible potential of ^{in vitro} transcribed RNA as a ground-breaking vaccine platform. Unlike traditional vaccines, RNA vaccines offer the exciting possibility of swift development and production, enabling rapid responses to emerging diseases. A recent breakthrough in RNA vaccine technology is the development of self-amplifying RNAs, which not only generate higher levels of immunogens but also require lower doses compared with conventional RNA vaccines.

This webinar will delve into the innovative world of self-amplifying RNAs as a cutting-edge RNA modality. Throughout the session, we will explore what self-amplifying RNAs are, how they differ from conventional RNA and their potential impact on shaping the next generation of RNA vaccines and other therapeutic applications.

Join Mark Shulewitz, PhD, senior scientist at GenScript for an enlightening discussion on the future of vaccine technology.

Speaker-related Webinars

Self-Amplifying RNA in Vaccines and Beyond

Self-Amplifying RNA in Vaccines and Beyond

Learn More